Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
Conclusion: In this prospective study using the prostate-specific membrane antigen–targeted PET agent 18F-DCFPyL, most patients with biochemical failure after radical prostatectomy had foci of suggestive uptake, even at low serum PSA levels.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Rowe, S. P., Campbell, S. P., Mana-Ay, M., Szabo, Z., Allaf, M. E., Pienta, K. J., Pomper, M. G., Ross, A. E., Gorin, M. A. Tags: Clinical Source Type: research
More News: Cancer | Cancer & Oncology | Nuclear Medicine | Prostate Cancer | Prostatectomy | Statistics | Study